Comerica Bank
NVCR icon

Comerica Bank’s NovoCure NVCR Stock Holding History

Comerica Bank’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,003
Closed -$387K – 2307
2021
Q2 		$387K Sell
3,003
-157
-5% -$30.5K ﹤0.01% 2092
2021
Q1 		$656K Sell
3,160
-373
-11% -$59K ﹤0.01% 1937
2020
Q4 		$597K Sell
3,533
-167
-5% -$22.9K ﹤0.01% 1942
2020
Q3 		$458K Sell
3,700
-32
-0.9% -$2.56K ﹤0.01% 1945
2020
Q2 		$249K Buy
3,732
+631
+20% +$41.5K ﹤0.01% 2105
2020
Q1 		$227K Buy
3,101
+116
+4% +$9.17K ﹤0.01% 2043
2019
Q4 		$256K Buy
+2,985
New +$241K ﹤0.01% 2119

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Comerica Bank's NVCR Position: Q3 2021 in Review

Comerica Bank sold out of NovoCure (NVCR) in Q3 2021, closing a stake of 3,003 shares — an estimated $387K sold.

Comerica Bank first reported a position in NVCR in Q4 2019 and held it in 7 quarters. The position peaked at $656K in Q1 2021. 317 funds tracked by Wall St. Rank hold NVCR as of Q3 2021.

  • Comerica Bank reported no remaining NovoCure position as of Q3 2021 after selling out during the quarter.
  • Comerica Bank sold 3,003 NovoCure shares in Q3 2021, an estimated $387K.
  • Comerica Bank first reported a position in NovoCure in Q4 2019 and held it in 7 quarters.
  • Comerica Bank's NovoCure position peaked at $656K in Q1 2021.
  • 317 funds tracked by Wall St. Rank held NovoCure as of Q3 2021.

Based on Comerica Bank's 13F filing for Q3 2021, filed 22 Nov 2021.